Rotary regenerative oxidizer
    23.
    发明授权
    Rotary regenerative oxidizer 失效
    旋转再生式氧化器

    公开(公告)号:US5967771A

    公开(公告)日:1999-10-19

    申请号:US118453

    申请日:1998-07-17

    摘要: A system for the abatement of industrial process gases utilizes a rotary regenerative oxidizer comprised of one or more heat exchange beds, each bed comprised of a parallel, axial, and longitudinal array of heat regenerative channels that thermally and/or catalytically oxidize contaminated gases. Utilizing a rotary regenerative oxidizer, and if desired, a plurality of heat regenerative beds incorporated therein, facilitates the use of regenerative technology at lower gas flow rates, increases thermal efficiency, and significantly reduces the floor space normally required when implementing fixed-bed nonrotary regenerative oxidizers. The heat exchange channels may be catalytically treated to enhance oxidation of the pollutants at a lower temperature.

    摘要翻译: 用于减少工业过程气体的系统使用由一个或多个热交换床组成的旋转再生氧化器,每个床由热和/或催化氧化污染气体的热再生通道的平行,轴向和纵向排列组成。 利用旋转式再生氧化器,如果需要,其中并入的多个热再生床有助于以更低的气体流速使用再生技术,提高热效率,并且在实施固定床非旋转再生时通常所需的占地面积显着降低 氧化剂。 可以对热交换通道进行催化处理,以在较低的温度下增强污染物的氧化。

    Catalytic method and device for controlling VOC. CO and halogenated
organic emissions
    26.
    发明授权
    Catalytic method and device for controlling VOC. CO and halogenated organic emissions 失效
    用于控制挥发性有机化合物的催化方法和装置。 CO和卤化有机物排放

    公开(公告)号:US5451388A

    公开(公告)日:1995-09-19

    申请号:US184312

    申请日:1994-01-21

    摘要: A method and device for treating a gas stream comprising at least one non-halogenated carbonaceous compound and optionally at least one halogenated organic compound. The gas stream, at 100.degree. C. to 650.degree. C. and in the presence of oxygen is contacted with a first catalyst in a first catalyst zone. The first catalyst comprises a first catalytic material deposited on a low acidity support material. In this zone, the non-halogenated compound is selectively reacted to form innocuous materials such as water and carbon monoxide. This can be followed by contacting the gas stream with a second catalyst in a second catalyst zone. The second catalyst comprises a second catalytic material deposited on a high acidity support material. In this zone, the halogenated organic compounds are reacted.

    摘要翻译: 一种用于处理包含至少一种非卤化碳质化合物和任选的至少一种卤化有机化合物的气流的方法和装置。 在100℃至650℃和氧气存在下,气流与第一催化剂区中的第一催化剂接触。 第一催化剂包含沉积在低酸度载体材料上的第一催化材料。 在该区域中,非卤化化合物选择性地反应以形成无害物质,例如水和一氧化碳。 这可以在第二催化剂区域中使气流与第二催化剂接触。 第二催化剂包含沉积在高酸性载体材料上的第二催化材料。 在该区域中,卤化有机化合物反应。

    Hydrothermally stable metal promoted zeolite beta for NOx reduction
    28.
    发明授权
    Hydrothermally stable metal promoted zeolite beta for NOx reduction 有权
    水热稳定的金属促进沸石β降低NOx

    公开(公告)号:US06914026B2

    公开(公告)日:2005-07-05

    申请号:US09948236

    申请日:2001-09-07

    摘要: The present invention is directed to an iron-promoted zeolite beta catalyst useful in the selective catalytic reduction of nitrogen oxides with ammonia in which the iron-promoted zeolite beta is treated so as to provide increased amounts of the iron promoter in the form of Fe(OH).The stabilized zeolite is formed by cation exchange of an iron salt into a zeolite beta which has a reduced sodium content such as by exchanging a sodium beta with ammonium or hydrogen cations. A zeolite beta having a reduced carbon content and a Si/Al ratio of no more than 10 also increases the Fe(OH) content of the iron-promoted catalyst. The iron-promoted catalyst which has the iron in the form of Fe(OH) is characterized by a peak at 3680±5 cm−1 in the IR spectra.

    摘要翻译: 本发明涉及可用于用氨选择性催化还原氮氧化物的铁促进的沸石β催化剂,其中处理铁促进沸石β以提供增加量的铁形式的铁促进剂(Fe 哦)。 稳定的沸石通过将铁盐阳离子交换成沸石β形成,沸石β具有降低的钠含量,例如通过用铵或氢阳离子交换钠β。 具有降低的碳含量和不超过10的Si / Al比的沸石β也增加了铁促进的催化剂的Fe(OH)含量。 具有Fe(OH)形式的铁的铁促进催化剂的特征在于IR光谱中在3680±5cm -1的峰。

    Acetylenic sulfonamide thiol tace inhibitors
    30.
    发明授权
    Acetylenic sulfonamide thiol tace inhibitors 失效
    乙酰磺胺硫胺止痛剂

    公开(公告)号:US06313123B1

    公开(公告)日:2001-11-06

    申请号:US09492974

    申请日:2000-01-27

    IPC分类号: A61K315375

    摘要: The compounds of formula B: which are useful in disease conditions mediated by TNF-&agr;, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss

    摘要翻译: 式B化合物,其可用于由TNF-α介导的疾病状态,例如类风湿性关节炎,骨关节炎,败血症,AIDS,溃疡性结肠炎,多发性硬化,克罗恩病和退行性软骨损失